Novel Biaryl Ring Compound as Immunomodulator Patent Application

The European Patent Office has published a patent application (EP2024125662A1) by Shanghai Longwood Biopharmaceuticals Co., Ltd. for a novel biaryl ring compound described as an immunomodulator. The application details the preparation and application of this compound, with designated states including most European countries.

EPO Patent for Bispecific Fusion Protein Targeting TNF-α and IL-17A

The European Patent Office has published patent application EP4635988A1 for a bispecific fusion protein targeting TNF-α and IL-17A, filed by Jiangsu Kanion Pharmaceutical Co., Ltd. The patent is related to therapeutic uses for conditions such as inflammation and autoimmune diseases.

EPO Patent Granted for Proximod Crystal Form

The European Patent Office has granted a patent (EP4635945A1) for a crystal form of Proximod, its preparation method, and its use. The patent was published on March 18, 2026, with applicants Jiankuan (Suzhou) Biotechnology Co., Ltd and the Institute of Materia Medica, Chinese Academy of Medical Sciences.

EPO Patent: Tetrahydrocyclopentyl Pyrrole Derivative Preparation and Use

The European Patent Office has published patent application EP4635949A1 concerning the preparation and use of a substituted tetrahydrocyclopentyl pyrrole derivative. The patent application lists Jiangsu NHWA Pharmaceutical Co., Ltd as the applicant and details various inventors.

Myostatin Inhibitor for Spinal Muscular Atrophy Treatment Patent

The European Patent Office has published a patent application (EP4518970A2) for Scholar Rock, Inc. concerning the use of a myostatin inhibitor for treating spinal muscular atrophy. The patent details specific chemical compounds and their therapeutic applications.

EPO Patent EP4518972A2 on Vectorized Anti-Complement Antibodies

The European Patent Office has published patent application EP4518972A2 filed by RegenxBio Inc. The patent covers vectorized anti-complement antibodies and related administration methods. The publication date is March 18, 2026.

EPO Patent Publication EP4526313A1: Trehalose-based Surfactants

The European Patent Office (EPO) published patent application EP4526313A1 on March 18, 2026, concerning trehalose-based surfactants developed by MedXCell SA. This publication details new chemical compounds and their potential applications in pharmaceutical formulations.

Patent EP4525868A1: Deuterated Domperidone for Gastroparesis

The European Patent Office has published patent application EP4525868A1, filed by CinDome Pharma, Inc., for deuterated domperidone intended for treating gastroparesis. The publication date is March 18, 2026.

EPO Patent Publication: Novel Composition for Hair and Scalp Condition

The European Patent Office has published a new patent application, EP4511051A1, detailing a novel composition for improving hair and scalp condition. The publication includes details on the applicants, inventors, and International Patent Classifications related to the composition.

CIPO Patent Practice Committee Meeting Notice - December 3, 2025

The Canadian Intellectual Property Office (CIPO) has published the agenda for its Patent Practice Committee meeting scheduled for December 3, 2025. The meeting will cover updates on CIPO operations, digital services, examination quality, and administrative policy matters, including budget impacts and agent-related updates.